Transform Your Weight Loss Journey with Advanced GLP-1 Therapy Safe, effective, and personalized weight management using the same active ingredient as FDA-approved semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro) treatments
In the 72-week study of more than 1,600 overweight or obese adults with Type 2 diabetes, those who received the 36-milligram highest dose of orforglipron on average shed 10.5% of their weight, or about 23 pounds, versus 2.2% for those who received a placebo, achieving the main goal of the trial
Khamashta, M
What if my semaglutide was left out
Yet, many patients find it difficult to continue the therapy
Gc t dol nguyn nhn hng u gy ra tn thng t bo, khin ADN v cc phn t protein b bin i